GATA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, miR-138, through a BCR-ABL/GATA-1/miR-138 circuit, is a tumor suppressor miRNA which is involved in the pathogenesis of chronic myeloid leukemia (CML) and may affect the clinical response to imatinib [1, 103].